UnitedHealth Group closed at $370.63, down 1.42% from the previous session, a bigger decline than the S&P 500's 0.47% loss. The largest U.S. health insurer is expected to report earnings on October 13, 2026, with analysts predicting EPS of $4.12, a 41.1% increase from the year-earlier quarter, and revenue of $111.38 billion, down 1.57% year over year. For the full year, the Zacks Consensus Estimates call for earnings of $19.85 per share and revenue of $446.78 billion, changes of +21.41% and -0.18% respectively from last year. Over the past 30 days the consensus EPS estimate has risen 0.15%, and UnitedHealth Group currently holds a Zacks Rank of #2 (Buy). The stock trades at a forward P/E of 18.94, a discount to its industry average of 21.09, with a PEG ratio of 1.41.
UnitedHealth Group IncorporatedEarnings preview with EPS estimate of $4.12 and Zacks #2 Buy rank; mixed signals as stock fell 1.42% ahead of the report.
Shanghai Henlius Biotech Inc